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The autoimmune disease experimental allergic encephalomyelitis (EAE)' can be
induced by the injection of myelin basic protein (MBP), or by injection of MBP-
specific Th into naive animals, and is considered to be a model for the study of neu-
rodegenerative disease mechanisms. EAE is characterized by an acute phaseofprogres-
sive hindlimb paralysis of varying severity. Histologically, autoimmune lesions of
EAE resemble that seen in human multiple sclerosis, which is also characterized
by acute neurological attacks (1-4).
Evidence that EAE is mediated by a T cell response subject to antiidiotypic modu-
lation (5, 6), similar to that seen in other systems such as graft-vs.-host resistance
(7, 8), suggests a limited idiotypic diversity for the disease inducing T cell reper-
toire, and as a corollary, the possibility of directed antiidiotypic therapy. We have
examined this critical idiotype repertoire using a monoclonal anti-T cell antibody
and have isolated and characterized the rat antigen-specific TCR. We found that
most, if not all, of the antiencephalitogenic response bears an idiotype defined by
this antibody (10 .18). We furthermore tested the ability of this antibody to block
the development of disease. Elimination of clinical disease was obtained.
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Materials and Methods
Animals.
￿
Female Lewis rats were obtained from Charles River Breeding Laboratories,
Inc., Wilmington, MA and were used at 8-12 wk of age. Female BALB/c mice were also
obtained from Charles River Breeding Laboratories, Inc.
Antigen.
￿
MBP from the spinal cords of guinea pigs (GP MBP) or from brains of Lewis
rats (rat MBP) was prepared as described previously (9). Synthetic peptides ofvarying lengths
with sequences corresponding to the encephalitogenic determinant of GP MBP were used
(9) and included the 73-88 sequence (GP14), the 71-88 sequence (GP16), and the 68-88 se-
quence (GP19) of GP MBP.
T Cell Hybridomas.
￿
The generation ofT cell hybridomas specific for GP14 (5.10), for GP
MBP (M3.35), or for OVA (B4) was carried out as described previously (9, 10) using popliteal
and inguinal lymph node cells from antigen-primed (50 Itmg/animal) Lewis rats. Hybridoma
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5.10 responded to all the encephalitogenic peptides, to GP MBP, and to rat MBP, whereas
M3 .35 responded to GP MBP but not to the peptides or to rat MBP B4 responded to OVA
but not to the peptides nor to MBP.
The T cell hybridoma assays in which lymphokine production was measured were done
according to the method described previously (9).
mAb.
￿
Establishment of an mAb to 5.10 was carried out according to the method, as de-
scribed (11) with modifications. In short, BALB/c mice were immunized three times in-
traperitoneally with 10' 5 .10 T cell hybrids emulsified in CFA (Difco Laboratories, Detroit,
MI) every other week. The spleens were removed 3 d after the last immunization and were
hybridized to Sp2/0. Supernatants from growing wells were tested for Ig synthesis, inhibition
ofT cell responses as measured by IL-2, and binding to cell surface molecules by FRCS anal-
ysis. The mAb was purified from the culture supernatant of hybridomas by using Affi-Gel
Protein A (Bio-Rad Laboratories, Richmond, CA) for experimental use. The isotype of 10.18
was determinedas IgG2a (kindly determinedby Dr. J. M. Liptock, Wistar Institute, Philadel-
phia, PA).
Control antibodies included a mouse IgM specific for Thy-1 .2 (12) and a mouse IgG2a
(H37-43-1Rl) specific for the hemagglutin ofinfluenza virus (kindly provided by W. Gerhard,
Wistar Institute).
FACS Analysis.
￿
105 cells were incubated with 10.18 (0.1 mg/ml) in PBS containing 1%
horse serum and 0.02% NaN3 for 30 min at 4°C. After washing twice, the cells were in-
cubated with FITC-labeled sheep F(ab')2 anti-mouse IgG (Jackson Immunoresearch, Avon-
dale, PA) precleared with rat Ig (Jackson Immunoresearch) for 30 min. The cells were washed
twice and analyzed with an Ortho 50 HH Cytofluorograf, connected to an Ortho 2150 Data
Handling System (Ortho Diagnostic Systems, Inc., Westwood, MA).
Radiolabelin .
￿
Labeling ofthe cell surface was carried out by the lactoperoxidase-catalyzed
method as described (13). 107 cells were washed five times with PBS and suspended in 1 ml
of 5 mM glucose in PBS containing 2 mCi 1251. Then, 20 wl of enzyme cocktail (100 U/ml
lactoperoxidase and 10 U/ml glucose oxidase) was added to the cell suspension and incubated
at room temperature for 15 min with occasional mixing. The cells were washed four times
with PBS containing 2 mM KI and 0.02% NaN3. Cells were lysed with 1 ml of lysis buffer
(1 ° Jo NP-40, 0.05 M iodoacetamide, 50 pM PMSF, and 10 mM EDTA in PBS) at 4°C for
20 min, and the supernatant was cleared by centrifugation at 12,000 g for 20 min and then
used for immunoprecipitation.
Immunoprecipitation.
￿
Aliquots of the cell lysate supernatant were incubated with appro-
priate mAbs at 4°C for 1 h, followed by precipitation of the immune complex using Afli-Gel
protein A for 3 h. The agarose beadswere then washed five times with 0.25% NP-40 in 0.45
M NaCl and once with 0.25% NP-40 in 0.15 M NaCl. The specifically bound material was
removed by boiling in the sample buffer for SDS-PAGE. In some cases, anti-mouseIg agarose
beads (Sigma Chemical Co., St. Louis, MO) were used.
Gel Electrophoresis.
￿
Two-dimensional (2D) SDS-PAGE was carried out according to the
method of Goding and Harris (14) using 12.5% acrylamide gel in both the first dimension
(nonreduced) and second dimension (reduced).
T Cell Lines.
￿
T cell lines were selected from the popliteal lymph nodes of Lewis rats im-
munized in the hind footpads (0.2 ml total) with 20 wg GP MBP (MBP line and purified
protein derivative of tuberculin [PPD] line) or OVA (OVA line) in H37Ra. 12 d later, the
popliteal lymph nodes were removed, ground to single cell suspensions, and washed twice
with PBS. The cells were cultured with 30 wg/ml ofrespective antigens at the cell concentra-
tion of 2 x 106/ml in ERPMI containing 1% fresh rat serum. Blast cells were separated on
a Ficoll (PharmaciaFine Chemicals, Piscataway, NJ) density gradient and then cultured without
antigens in ERPMI containing 10% horse serum supplemented with 5% rat growth factor
for 7 d. The cells (5 x 105/ml) were restimulated with 10 ug/ml respective antigens in the
presence of 5 x 106/ml x-irradiated thymocytes (3,000 rad). After five cycles of stimulation,
the MBP line (MTll, M5) responded to GP MBP, rat MBP, GP16, and GP19, but not to
PPD or OVA. The PPD line (PT7) or OVA line (OT4) responded only to respective-specific
antigens, but not to MBPs or encephalitogenic peptides.
T Cell Proliferation Assay.
￿
Lymph node cells from immunized rats were tested for antigenOWHASHI AND HEBER-KATZ
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specificity by adding 4 x 105 cells to 2 x 105 x-irradiated spleen cells from normal rats in
flat-bottomed 96-well plates (Costar, Cambridge, MA). Antigen was added at the indicated
concentration. 72 h after the initiation ofculture, [3H]thymidine was added to measure the
degree of DNA synthesis.
Induction ofEAE.
￿
Animals were immunized in both hind footpads with a total of 0.2 ml
ofa 1 :1 emulsion ofthe appropriate antigen in saline and H37Ra adjuvant (Difco Laborato-
ries). Thus, each rat received a total of 100 gg of mycobacterium and 1-100 wg of protein.
Rats were observed daily until clinical signs disappeared in affected animals, or for 3-4 wk
if no clinical signs appeared.
Determination of Histological EAE.
￿
Animals were killed on day 18 after injection of MBP
and whole spinal columns were removed by dissection. After fixing in 10% buffered formalin
for 14 d, the cords were removed whole and sectioned into 7-10 fragments 0.7 cm in length.
The sections were dehydrated with absolute ethanol followed by chloroform, arranged side
by side, and embedded in paraffin. The paraffin blocks were sliced to reveal cross-sections
of the cord segments, which were stained with hematoxylin and eosin. The slides were evalu-
ated by Dr. L. Rourke (Department of Pathology and Laboratory Medicine, University of
Pennsylvania School of Medicine).
Results
To produce the desired andidiotypic antibody, we chose a rat-mouse T cell hy-
bridoma, 5.10, specific for the encephalitogenic determinant ofMBP (residues 68-88).
This hybrid was made from a fusion of the mouse BW5147 AKR thymoma and
an encephalitogenic peptide-stimulated Lewis rat T cell culture, which upon transfer
could cause EAE, and was then used to immunize BALB/c mice.
Out of 400 mAbs tested, one, 10.18, showed the characteristics of an anticlono-
typic antibody. As shown in Fig. 1 A, 10.18 bound only to the encephalitogenic peptide-
specific T cell hybridoma 5.10, but not to the parental AKR thymoma BW5147,
nor to an OVA-specific T cell hybridoma, 134, by FAGS analysis. This binding specificity
of 10 .18 was confirmed by using "'I-labeled 10.18 (data not shown).
One criterion for an antibody directed to a cell surface activation molecule such
as the TCR is the ability to cause either (a) the inhibition of T cell activation by
antigen or (6) the activation of T cells in the absence of antigen. The latter case
has been shown to require multivalency for its effect (15) . We first examined the
effect of 10.18 on IL-2 production by antigen-stimulated cultures ofB4, 5.10, or M3.35,
(an MBP non-68-88-specific T cell hybrid) (Fig. 1 B). IL-2 production from 134
or M3 .35 was not inhibited at any concentrations of 10.18 tested. On the contrary,
10.18 clearly inhibited IL-2 production from 5.10, the maximal inhibition being ob-
served between 10 and 50 ng/ml. This inhibitory effect was lost at the highest con-
centration (10 gg/ml) of 10.18. A control r2a mAb, H37-43-1R1, did not inhibit IL-
2 production from 5.10 (data not shown). The degree ofIL-2 production in the pres-
ence of immobilized 10.18 was also examined as shown in Fig. 1 C. Serially diluted
10.18-coated 96-well flat-bottomed tissue culture plates were prepared and hybrid-
omas were added in the absence of antigen and APC. No IL-2 production was ob-
served from BW5147, B4, or M3 .35 . However, remarkable IL-2 production from
5.10 occurred even in wells that were coated with the lowest concentration (0.02 wg/ml)
of 10.18. Similar results were obtained by using 10.18-coupled Sepharose beads (data
not shown).
The ability of 10.18 to function as described above strongly indicated that it bound
to a clonotypic marker, putatively the TCR. To demonstrate that this was indeed2156
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FIGURE 1.
￿
(A) Binding speci-
ficity of 10.18 to T cell hybrid-
omas by FACS analysis. FAGS
analysis of parental thymoma
13W5147
￿
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hybridoma B4, MBP 68-88-
specific T cell hybridoma5.10,
or MBP-specific Tcell hybrid-
oma M3.35 was done with
( ) or without (----)
10.18. (B) Inhibition of IL-2
production from Tcell hybrid-
omas by 10.18. Variousconcen-
trations of 10.18wasaddedto B4
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+ OVA, 5.10 + GP MBP, or
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Aftera24-h incubation, thesu-
pernatantwas assayed forIL-2.
(C)Production of IL-2 from T
cell hybridoma by 10.18-coated
plate. IL-2 production from
BW5147, B4, 5.10, or M3.35 at
the concentrationof 105/ml(O)
or 3 x 105/ml (") was exam-
ined by using 96-well flat-bot-
tomed microtiter plate coated
with 10.18. Aftera24-h incuba-
tion, the supernatant was as-
sayed for IL-2.
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the TCR and not another molecule expressed only on 5.10, we analyzed the struc-
ture of this cell surface molecule by 2D SDS-PAGE. Cell surface proteins were la-
beled with 1251 by the lactoperoxidase method (13) and a cell membrane lysate was
precipitated with 10.18 and run on a 2D gel. As shown in Fig. 2 A, the precipitated
molecule had an apparent molwt of 76,000 in thenonreduced dimension (horizontal).
This molecule was separatedinto 48,000- and 39,000-mol wt components afterreduc-
tion. The spot on the diagonal line with some tailing of apparent mol wt of
44,000-46,000 could be the monomeric form of the TCR (16). SP2/0 culture super-
natant did not precipitate these molecules (Fig. 2 B), nor did a control antibody,
a murine IgM specific for mouse antiThy-1.2 (12) (data not shown).
Given the fact that previous work had suggestedthat EAE could be clonotypically
modulated (5, 6), we were interested in thepossibility that 10.18 recognized a receptor
present, notonly on 5.10, buton arepresentative T cell population that was antigen
specific (68-88) and that could cause disease. We examined the binding specificity
of 10.18 using four established rat T cell lines: PT7 (specific to PPD), OT4 (specific
to OVA), MTll, and M5 (both specific to MBP). Long-term MBP-specific lines such
as MTI1 and M5 have been shown in ourlaboratory to be capable of inducing EAE
when adoptively transferred to normal rats (9). As shown in Fig. 3, 10.18 did not
bind to either PT7 or OT4. On the contrary, 10 .18 bound to x+65% of MT11 and
most, ifnot all, of the population ofM5 that was generatedindependently from MT11 .We were of course interested in the expression of the 10.18 idiotype on in vivo
T cell populations. Since 10.18 showed characteristics of an antiidiotypic antibody
to a rat TCR specific for the encephalitogenic determinant of MBP, we examined
the difference in expression betweenT cells from normal rats and those from para-
lyzed rats that were immunized withMBPAs shown in Table 1, 10.18 cells are very
rare in thymus and lymph node cell ofnormal rats . A modest increase in 10.18 cells
was observed in thymocyte, spleen, and lymph node cells in the MBP-primed para-
lyzed rats, the greatest increase being observed in spleen. An augmentation of
10.18+ cells was observed when cells from MBP-primed rats were cultured in vitro
for 3 d with 10 pg/ml of GP MBP .
The critical test of the idiotypic nature of the autoimmune disease EAE is the
ability of 10.18 to modulate disease . We therefore injected Lewis rats with GP MBP
to induce EAE. As seen in Fig . 4, injection of 10.18 ascites into rats on day 0, 2,
and 4 afterMBP resulted in near ablation of clinical disease . This was not seen in
rats injected with a control ascites or with saline .
To determine ifthis antibody was eliminatingthe cell populations involved in dis-
ease, we examined both the recirculation of cells into the spinal cord and the ability
ofTcells in the periphery to respond to antigen . Spinal cord and lymph nodes were
removed from these rats on day 18 afterMBP, atime in whichthe disease symptoms
hadjust subsided . Upon examination of spinal cord sections (Fig . 5), we found to
d
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FIGURE 2 .
￿
2D SDS-PAGE analysis of 125I-labeled surface proteins precipitated with 10.18 . The
lysates of 125I-labeled cell surface proteins were precipitated with 10.18 (Fig . 2 A) or Sp2 0 cul-
ture supernatant (Fig . 2 B) .The precipitate was subjected for 12.5% 2D SDS-PAGE under non-
reducing conditions at first dimension and under reducing condition at second dimension .
Fluorescence intensity
FIGURE 3 .
￿
Binding specificity of 10.18
to Lewis rat T cell linesby FRCS anal-
ysis . FACS analysis of(A) PPD-specific
T cell line PT7, (B) OVA-specificT cell
line OT4, (C) MBP-specificT cell line
MT11, or (D) M5 was done with
(
￿
) or without (----) 10.18 .2158
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TABLE I
Binding of 10.18 to Thymocyte, Spleen, or Lymph Node Cell From
Normal MBP-primed Lewis Rats Analyzed by FACS
Paralyzed Lewis rats that were immunized with 25 wg GP MBP in H37Ra at
13 d before. Cells were cultured with 10 gg/ml GP MBP for 3 d,
our surprisethat both theprotected (10.18 injected) and unprotected (control ascites
injected) animals showed similar perivascular cuffing, a hallmark of EAE.
On the other hand, these two groups ofanimals showed differences in prolifera-
tive T cell responses. As seen in Fig. 6, in the unprotected animals that just recov-
ered from severe disease, there was reduced or no proliferation to either MBP or
PPD. Inthe animals that received 10.18 andhadnoclinicalsymptoms, Tcell prolifer-
ative responses were seen to both MBP and PPD; however, the response to the en-
cephalitogenic determinant was absent.
We also examined the ability ofvarying amounts ofthe 10.18 antibody to protect
from disease. In the first experiment, seen in Table II, one dose of antibody given
either on day 0 or 5 afterMBP caused reduction in the numberofdiseased animals,
in the severity ofdisease, and delayed the day ofonset. In the second experiment,
alsoseen inTable II, verylowdoses ofpurifiedantibody caused reductionofdisease.
Discussion
The antigen receptors ofseveral T cell clones orhybridomas derived from mouse
(16, 17) and human (18, 19) have been identified using antiTCR antibodies. How-
ever, the rat TCRhas not yetbeen characterized dueto the difficulty ofestablishing
stable T cell clones ofthis species. Recently, our laboratory established a stable rat-
mouse T cell hybridoma, 5.10, by hybridizing MBP-primed rat lymph node cells
with the BW5147 AKR mouse thymoma (9, 10). By using 5.10 as a immunogen,
we have generated an mAb, 10.18, that shows clonotypic specificity.
The TCR consists of a disulfide-linked, glycosylated heterodimer of two chains,
a and a. The mol wt ofeach chain is 49,000 and 43,000, respectively, in human
FIGURE 4.
￿
Kinetics of EAE symptoms in Lewis rats given
GP MBP and treated with mAbs. Lewis rats (three
animals/group) were injected with 25 ug GP MBP in CFA
in thehind footpads and also were injected intraperitonealy
with saline (Q), a control monoclonal anti-influenza as-
cites (/), and 10.18 ascites (A) on days 0, 2, and 4.
Rats
Percentage
Thymus
of 10.18'
Spleen
cell from:
Lymph node
Normal 0.2 1.9 0
MBP primed 0.6 5.3 1.1
MBP primed + cultured 4.0 16.7 8.1OWHASHI AND HEBERKATZ
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FIGURE 5 .
￿
Hematoxylin- and eosin-stained sections of Lewis rat spinal cord taken at day 18
afterMBPrevealed inflammation with prominent perivascular cuffing in the white matter. This
was seen in both (A) unprotected rats given a control antibody and having severe clinical symp-
toms and (B) protected rats given the mAb 10.18 and having no clinical symptoms. (x 200) .
(19) and 40,000-44,000 in mouse (16, 17) . In this study, we identified a clonotypic
marker on MBP-specific rat T cells and on an MBP-specific rat-mouse T cell hy-
bridoina with structure and biological activity similar to themouseandhumanTCR.
By 2D SDS-PAGE, it appears to be an a,(3 heterodimer consisting of chains of48,00021AB￿
Ascites control (day 18)
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Saline control (day 18)
and 39,000 mot wt mAb 10.18, which precipitates this molecular complex, clearly
inhibited IL-2 production by the MBP 68-88-specific T cell 5.10 but not an Mk-
specific Tcell. This inhibitory effect of soluble 10.18 was lost at thehighest concen-
tration of 10.18, possibly due to a stimulatory effect by the antibody (15). On t
other hand, apparently low concentrations of plate-immobilized 10.18 stimulated
thehybridoma 5.10 to produce IL-2 butdidnot stimulatetheOVA hybridoma. These
effects arecharacteristic of anti-TCR antibodies (15). A stimulatory action hasbeen
observed with anti-T cell antibodies directed to T3, T11 (20), T44 (21), and Thy-I
(22). However, stimulation in these cases is not clonotypically restricted, in contrast
to 1118.
We examined the binding (by FAGS analysis) of 10.18 to not only T cell hybrid-
omas and the mouse fusing line, but also to normal rat lymphocyte populations to
confirmthat the marker wasnot Ily1widoma specific. 10.18 clearlyboundto themajority
of the cells of the MP-specific long-term T cell lines MT11 and M5 and not at
CPM X 10-3
10.18 (day 18)
.
￿
Proliferation of lymph node cells from Lewis
rat! givenGP MBP andtreated with (A) saline, (B)control
ascites, and (C) 10.18ascites. Afterdisease symptoms had
subsided (day 18, see Fig. 4), lymph nodes were removed
and cells were assayed for proliferation to GP MBP (50
gg/ml), the synthetic encephalitogenic peptide 68-88 or
GPE 19 (10 itg/ml), PPD (2 gg/ml), and Con A (4 vg/ml),OWHASHI AND HEBER-KATZ
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TABLE II
Blocking of EAE with the Anti-T Cell ldiotype 10.18
GP MBP was emulsified in CFA and 0.2 ml was injected into hind footpad
of normal Lewis rats. Antibody was injected as indicated.
$ 1 :20 dilution of ascites, 0 .5 ml intraperitoneally.
S Purified antibody injected intraperitoneally .
II 0.03 ug antibody given on days 0, 2, 4, 6, 8, and 10 after MBP.
allto the OVA- and PPD-specificlines, indicating thatthemarker ispresent onantigen-
specific normal cells and may function as a physiologically significant idiotype that
is involved in the regulation ofthe encephalitogenic response. It is important to note
that such long-term Tcell lines are made upofpredominantly 68-88-specific Tcells
that are ofpolyclonalorigin as determinedby TCRa chain constant region Southern
blot analysis (23). Thus, in a fusion of BW5147 and a long-term T cell line, seven
out ofseven 68-88-specific hybridomas were ofdifferent clonal origin. The proba-
bility ofdrawing such a sample is 6% for a population of10 different 68-88-specific
clones and 49% for a population of 32 different clones, the majority ofwhich also
bear the idiotype recognized by 10.18. Therefore, we believe that we are notlooking
here at two independently derived cell lines that are all monoclonal and identical
to 5.10, butrather thatthese lines arecomposed ofdiversepopulationsofMBP 68-88-
specific T cells that are reasonably representative ofthe normal idiotypic diversity
ofthe MBP 68-88 response in general. This interpretation is reinforced by the ob-
servation thatantibody 10.18blocks EAEinvivo. Weconclude that theMBP-specific
Lewis rat T cell lines, which are capable ofinducing severe EAE in naive rats, ex-
press a specific TCR idiotype detectable with mAb 10.18. Though 10.18' T cells
are rare in normal rats, an increase of 10.18 T cells was observed in thymocyte,
spleen, andlymph node cells ofparalyzed rats thatwere immunizedwithMBP Clinical
signs ofEAE were eliminated usinglow doses ofantibody (0.18-75 wg/animal), sup-
porting the idea that the idiotype recognized by 10.18 is important in the disease-
inducing lymphocyte repertoire. What was particularly interesting, however, was
the fact that the 10.18-protected animals, which showed no signsofdisease, and whose
lymph node Tcells showed no response tothe encephalitogenic determinant ofMBP,
but normal responses to whole MBP and PPD, did have cells that migrated to the
spinal cord in a manner indistinguishable from sick (unprotected) animals. One
explanation is that the cells seen in the spinal cord are activated T cells ofirrelevant
Exp. GP MBP' Antibody
Numbers
of animals
Day of
onset
Average state
of disease
kg/animal
I1 100 None 3/3 12 3
100 10 .18 d.0 1/3 18 0 .3
100 10 .18 d.5 1/3 16 0 .3
100 IgG2a control 3/3 12 3
0 10.18 da .0 0/3 None None
2$ 5 None 3/3 12 3.7
5 0.3 4g (d0) 1/3 13 0.7
5 0.03 wg (x 6)I1 0/3 None None
50 None 3/3 11 3
50 0.03 Rg (x 6)11 1/3 13 1 .32162
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specificity and are not at all involved in the disease. A second explanation is that
T cells that are MBP 68-88 specific are the cells found in the perivascular cuffs but
that these cells are blocked in some way through their antigen receptors. A third
explanation is that 10.18 is actually blocking the interaction with a regulatory T cell
(10.18 like) that is specific for the anti-MBP 68-88 TCR and that perhaps, in an
attempt to turn offthe MBP-specific T cell, delivers adestructive signal in thespinal
cord .
Any number of possibilities can be generated to explain this finding. However,
at present it is known that there are other cases in which clinical symptoms and
histology do not correlate (24, 25). One especially striking example in a different
disease system is the nonobese diabetic mouse in which lymphocytes migrate to the
pancreas resulting in insulitis though the animal remains symptom-free until 3 mo
later when thecellsbecome active and destroythe R cellscausing diabetes (26), though
similar findings have been seen in cell transfer experiments into normal animals (27).
It has also been shown in the PL/J, (PL x SJL)F1, and B10YL mouse that a
commonly used V region of the TCR a chain, VR 8.2, is used by -75% of clones
that respond to the encephalitogenic determinant of MBP A known anti-V Q anti-
body, F23.1 (28), hasbeen shown to block active disease (29, 30). This is very similar
to our findings in the Lewis rat where all the T cells involved in EAE used a TCR
Q chain V region homologous to V R 8.2 (31). At present, however, we do not know
if our antibody, 10.18, recognizes a V region or an idiotypic determinant.
Thus, we would conclude that it is probable that 10.18' T cells constitute the
dominant pathogenic Tcell repertoire of the autoimmune disease EAE in the Lewis
rat. We would thus characterize EAE as a "mono- idiotypic" autoimmune disease.
Summary
Immunizing Lewis rats with guinea pig myelin basic protein (MBP) yielded an
encephalitogen specific, la-restricted, rat-mouse T cell hybridoma 5.10, which was
used to establishaclonotypic mAb (10.18) that bindsto andprecipitates theratTCR.
By two-dimensional gel electrophoresis, the rat TCR was shown to consist of two
disulfide-linked peptide chains with mol wt of 48,000 and 39,000. 10.18 binds the
majority of cells in MBP-specific T cell lines that are capable of transferring ex-
perimental allergic encephalomyelitis (EAE) to Lewis rat recipients, but does not
bind to either apurified protein derivative oftuberculin-specific cell line or an OVA-
specific line. Furthermore, soluble 10.18 can block antigen-specific stimulation of
hybridoma5.10 but cannot control hybridomas, while immobilized 10.18 stimulates
5.10, but cannot control the hybrids. Though 10.18' cells are very rare in normal
rats, increase of 10.18' cells is observed in MBP-primed paralyzed rats. Finally,
when 10.18 is injected into MBP-primed Lewis rats, EAE is abrograted. We have
thus characterized EAE as a "mono-idiotypic" autoimmune disease.
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